Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

A legfontosabb adatok

Ki végzi
Xeltis
Hol
Costa Rica1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
6 fő, tervezett
Kezdés
2025. máj. 2.
Várható befejezés
2028. dec.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
A regiszteradat frissítve
2026. október 6.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt
A regiszter összes feltétele (27)A regiszter feltételeinek elrejtése

Ki vehet részt

  • Subjects with femoral artery occlusion who require elective above-knee femoral popliteal bypass surgery
  • Patient has Rutherford grade 3, 4, or 5 occlusive vascular disease and TASC C or D lesions. Rutherford grade 5 may be included with a wound, ischemia and foot infection (WiFi) classification of up to grade 2, provided there are two outflow vessels with at least one reaching the pedal arch
  • At least 18 years of age at screening
  • Suitable anatomy (assessed by a pre-procedural contrasted CT scan or previous angiogram assessed up to 90 days prior to baseline)
  • Patient has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent
  • Patient has been informed and agrees to pre- and post-procedure follow-up, including follow-up angiography
  • Life expectancy of at least 24 months

Ki nem vehet részt

  • Stroke or myocardial infarction event within 6 weeks of the procedure or evidence of prior massive stroke (Modified Rankin Scale 3 or above)
  • Previous renal transplant
  • Previous enrolment in this study
  • Unsuitable anatomy to implant the XPAD conduit (e.g. target vessel diameter smaller than anticipated; severe calcification)
  • Subject requires, or is scheduled for, a cardiac surgical procedure or a different vascular surgical procedure within 30 days of study procedure
  • Presence or history of bypass in the diseased limb
  • History of acute arterial occlusion requiring an emergent intervention
  • Uncontrolled arterial hypertension (BP >200 mmHg) at 2 successive readings
  • Uncontrolled or poorly controlled diabetes
  • Any active local or systemic infection
  • Known active bleeding disorder and/or any coagulopathy or thromboembolic disease
  • Allergies to study device (nitinol) or agents/medication, such as contrast agents or aspirin, that can't be controlled medically
  • Any other condition which, in the judgement of the investigator would preclude adequate evaluation for the safety and performance of the study conduit; Intra-operative exclusion criteria:
  • Severe chronic renal insufficiency (serum creatinine >2.5 mg/dL) or undergoing hemodialysis
  • Reduced liver function, defined as: >2x the upper limit of normal for serum bilirubin, International Normalized Ratio (INR) >1.5 or prothrombin time (PT) >18 seconds
  • Subject requires sequential extremity revascularizations or other procedures that require use of additional vascular grafts
  • Abnormal blood values that could influence patient recovery and or/ graft hemostasis
  • Known heparin-induced thrombocytopenia
  • Subject is participating in another study
  • Pregnant or breastfeeding woman or woman in fertile period not taking adequate contraceptives

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

A prospective, single arm, non-randomized early feasibility study to evaluate the preliminary safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective above-knee femoral popliteal bypass surgery.

A vizsgálat csoportja

  • XPAD Bypass ConduitA vizsgált kezelés

    Kezelés: Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Prospective, Non-randomized, Early Feasibility Clinical Study to Assess the Feasibility of the Novel Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
A regiszteradat frissítve
2026. október 6.